/ CBD Content for 51³Ô¹ÏºÚÁÏ Davis en /blog/rise-pseudocannabinoids <p>Developing pseudocannabinoids, synthetic molecules that mimic the activity of molecules found in cannabis plants, is the goal of research by Professor Mark Mascal in the 51³Ô¹ÏºÚÁÏ Davis Department of Chemistry. Mascal recently received a $30,000, one-year seed grant, the <a href="https://chemistry.ucdavis.edu/donors">Dr. Mohsen Najafi Research Award in Medicinal Chemistry</a>, to advance his work.&nbsp;</p> April 02, 2025 - 11:07am Andy Fell /blog/rise-pseudocannabinoids /news/synthetic-version-cbd-treats-seizures-rats <p>A synthetic, non-intoxicating analogue of cannabidiol (CBD) is effective in treating seizures in rats, according to research by chemists at the University of California, Davis. The synthetic CBD alternative is easier to purify than a plant extract, eliminates the need to use agricultural land for hemp cultivation, and could avoid legal complications with cannabis-related products. The work was recently published in the journal&nbsp;<em><a href="https://rdcu.be/bEH8b">Scientific Reports</a></em>.&nbsp;</p> May 28, 2019 - 8:52am Andy Fell /news/synthetic-version-cbd-treats-seizures-rats